Controversies in radioiodine therapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goitres.

@article{Bonnema2002ControversiesIR,
  title={Controversies in radioiodine therapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goitres.},
  author={Steen Joop Bonnema and Luigi Bartalena and Anthony D Toft and Laszlo Heged{\"u}s},
  journal={European journal of endocrinology},
  year={2002},
  volume={147 1},
  pages={1-11}
}
In routine use for more than 50 years, radioiodine ((131)I) is generally considered safe and devoid of major side effects. Therefore, it is surprising that relatively many aspects of radioiodine therapy are controversial, as illustrated by recent international questionnaire studies. Our review aims at highlighting three of these areas - namely, the influence of (131)I on the course of Graves' ophthalmopathy, the possible radioprotective effects of antithyroid drugs, and the use of (131)I in… CONTINUE READING
12 Citations
93 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 93 references

Management of the nontoxic multinodular goiter: a North American survey

  • SJ Bonnema, FN Bennedbæk, PW Ladenson, L. Hegedüs
  • Journal of Clinical Endocrinology and Metabolism
  • 2002

A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter

  • MF Wesche, MM Tiel-Van Buul, P Lips, NJ Smits, WM. Wiersinga
  • Journal of Clinical Endocrinology and Metabolism
  • 2001

Similar Papers

Loading similar papers…